Skip to main content
Log in

Autoimmune thyroid disorders—An update

  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Background: Autoimmune thyroid disease (AITD), a common organ specific autoimmune disorder is seen mostly in women between 30–50 yrs of age. Thyroid autoimmunity can cause several forms of thyroiditis ranging from hypothyroidism (Hashimoto’s thyroiditis) to hyperthyroidism (Graves’Disease). Prevalence rate of autoimmune mediated hypothyroidism is about 0.8 per 100 and 95% among them are women. Graves’ disease is about one tenth as common as hypothyroidism and tends to occur more in younger individuals. Both these disorders share many immunologic features and the disease may progress from one state to other as the autoimmune process changes. Genetic, environmental and endogenous factors are responsible for initiation of thyroid autoimmunity. At present the only confirmed genetic factor lies in HLA complex (HLA DR-3) and the T cell regulatory gene (CTLA 4). A number of environmental factors like viral infection, smoking, stress & iodine intake are associated with the disease progression. The development of antibodies to thyroid peroxidase (TPO) thyroglobulin (TG) and Thyroid stimulating hormone receptor (TSH R) is the main hallmark of AITD. Circulating T Lymphocytes are increased in AITD and thyroid gland is infiltrated with CD4+ and CD8+ T Cells. Wide varieties of cytokines are produced by infiltrated immune cells, which mediate cytotoxicity leading to thyroid cell destruction. Circulating antibodies to TPO and TG are measured by immunofluorescense, hemagglutination, ELISA & RIA. TSHR antibodies of Graves’ disease can be measured in bioassays or indirectly in assays that detect antibody binding to the receptor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Canaris, G.J., Manowitz, N.R., Mayor, G.M. and Ridgway, E.C. (2000) The Colorado thyroid disease prevalence studies. Arch. Int. Med. 160, 526–534.

    Article  CAS  Google Scholar 

  2. J. Larry J. and A.P. Weetman (2001) Disorders of the Thyroid gland, In: Harrison’s Principles of Internal Medicine, 15th Edn, Vol.2, Eds. E. Brunwald and A. Fauci Mc Graw-Hill Publication, USA. p 2060–2084.

    Google Scholar 

  3. Marcocci, C., Chiovato, L. (2000) Thyroid-directed antibodies, In: The Thyroid: A Fundamental and Clinical Text. 8th ed. Eds. Braverman LE, Utiger RD, Lippincott Williams & Wilkins, Philadelphia. p 414–31.

    Google Scholar 

  4. Weetman, A.P., McGregor, A.M. (1994) Autoimmune thyroid disease: Further developments in our understanding. Endocr. Rev. 15, 788–830.

    Article  PubMed  CAS  Google Scholar 

  5. Brix, T.H., Kyvik, K.O., Christensen, K., Hegedus, L. (2001) Evidence for a major role of heredity in Graves’ disease: a population-based study of two Danish Twin cohorts. J. Clin. Endocrinol. Metab. 86, 930–934.

    Article  PubMed  CAS  Google Scholar 

  6. Ban Y., Tomer, Y. (2003) The contribution of immune regulatory and thyroid specific genes to the etiology of Graves’ and Hashimoto’s disease. Autoimmunity. 36(6–7), 367–79.

    Article  PubMed  CAS  Google Scholar 

  7. Weetman, A.P. (2000) Endocrinology. In: Handbook of HLA and Disease, 2nd Edn. Eds: Lechler RI, Warrens A. Academic Press, London.

    Google Scholar 

  8. Onuma, H., Ota, M., Sugenoya, A., Inoko, H. (1994) Association of HLA-DPB-0501 with early-onset Graves’ disease in Japanese. Hum Immunol 39, 195–201.

    Article  PubMed  CAS  Google Scholar 

  9. Tandon, N., Mehera, N.K., Taneja, V., Vaidya, M.C., Kochupillai, N. (1990) HLA antigens in Asian Indian Patients with Graves’ disease. Clin Endocrinol (oxf) 33, 21–26.

    Article  CAS  Google Scholar 

  10. Omar, M.A., Hammond, M.G., Desai, R.K., Motala, A.A., Aboo, N., Seedat, M.A. (1990) HLA class I and II antigens in South African blacks with Graves’ disease. Clin Immunopathol 54, 98–102.

    Article  CAS  Google Scholar 

  11. Furugaki K. Shirasawa S, Ishikawa N, Ito K, Kobota S, Kuma K, Tamai H, Akamizu T, Hiratani H, Tanaka M, Sasazuki T, (2004) Association of the T-cell regulatory gene CTLA4 with Graves’ disease and autoimmune thyroid disease in the Japanese. J. Hum. Genet. 49 (3), 166–8.

    Article  PubMed  CAS  Google Scholar 

  12. Ueda, H., Howson, J.M., Esposito, L., (2003) Association of the T-Cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature, May 29. 423(6939), 506–11.

    CAS  Google Scholar 

  13. Pei-Win Wang, Rue-Tsuan, Liu, Suh-Hang Hank Juo et al, (2004) Cytotoxic T Lymphocyte-Associated Molecule-4 Polymorphism and Relapse of Graves’ Hyperthyroidism after Antithyroid withdrawal, The J. Clin. Endocrinol. Metab. Vol.8 No. 1, 169–173.

    Article  CAS  Google Scholar 

  14. Noel, R.R., Raphael, B. and Burek, C.L. (2002). Iodine: an environmental trigger of thyroiditis. Autoimmun. Rev. Feb Vol. 1 (1–2), 97–103

    Google Scholar 

  15. Tomer, Y., Davies, T.F. (1993) Infection, thyroid disease and autoimmunity. Endocr. Rev. 14, 107–120.

    Article  PubMed  CAS  Google Scholar 

  16. Jaspan, J.B., Sullivan, K., Garry, R.F. (1996) The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves’ disease. J. Clin. Endocrinol. Metab. 81, 2271–2279.

    Article  PubMed  CAS  Google Scholar 

  17. Bartalena, L., Bogazzi, F., Tanda, M.L. (1995). Cigarete smoking and the thyroid. Eur. J. Immunol. 133, 507–512.

    CAS  Google Scholar 

  18. Strieder, T.G., Prummel, M.F. (2003) Risk factors for and prevalence of thyroid disorders in a cross sectional study among healthy female relatives of patients with autoimmune thyroid disorder. Clin Endocrinol (OXF) Sep, 59(3), 396–401.

    Article  Google Scholar 

  19. Prasad KV, Prabhakar BS, (2003) Apoptosis and autoimmune disorders, Autoimmunity, 36(6–7), 323–30.

    Article  PubMed  CAS  Google Scholar 

  20. McLachian, S.M., Rapport B. (1992) The molecular biology of thyroid peroxidase: Cloning, expression and role as autoantigen in autoimmune thyroid disease. Endo. Rev. 13, 192–206.

    Article  Google Scholar 

  21. McIntosh, R., Waston, P, Weetman A. (1998) Somatic hypermutation in autoimmune thyroid disease. Immunol. Rev. 162, 219–231.

    Article  PubMed  CAS  Google Scholar 

  22. Silva, L.M., Chavej, J., Canalli, M.H., Zanetti, C.R. (2003) Determination of IgG sub classes and avidity of antithyroid peroxidase antibodies in patients with subclinical hypothyroidism—a comparison with patient with overt hypothyroidism. Horm Res. 59(3), 118–24.

    Article  PubMed  CAS  Google Scholar 

  23. malthiery, Y., Lissitzky, S. (1987) Primary structure of human Thyroglobulin deduced from the sequence of its 8848-base complementary DNA. Eur. J. Biochem. 105, 491–498.

    Article  Google Scholar 

  24. Canayanniotis, G., Rao, V.P. (1997) Searching for pathogenic epitopes in Thyroglobulin: Parameters and caveats. Immunol. Today. 18, 83–88.

    Article  Google Scholar 

  25. Brown, T.R., Zhao, G., Palmer, K.C. (1997): Thyroid injury, autoantigen availability and the initiation of autoimmune thyroiditis. Autoimmunity. 27, 1–12.

    Google Scholar 

  26. Collison, K.S., Banga, J.P., Barnett, P.S. (1991) Autoantibody stimulation of the human thyrotropin receptor: Regulation of adenlyate cyclase activity, Thyroglobulin and thyroid peroxidase mRNA levels in primary cultures of Graves’ thyroid tissue. Clin. Exp. Immunol. 86, 61–5.

    PubMed  CAS  Google Scholar 

  27. Prabhakar, B.S., Fan J.L., Seetharamaiah, G.S. (1997) Thyrotropin-receptor-mediated diseases: A paradigm for receptor autoimmunity. Immunol. Today. 18, 437–442.

    Article  PubMed  CAS  Google Scholar 

  28. Ajjan, R.A., Findlay, C., Metcalfe, R.A. (1998) The modulation of the human sodium iodine symporter activity by Graves’ disease sera. J. Clin. Endocrinol. Metab. 83, 1217–1221.

    Article  PubMed  CAS  Google Scholar 

  29. Stassi G, De Maria R, (2002), Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat. Rev. Immunol. 2(3), 195–204.

    Article  PubMed  CAS  Google Scholar 

  30. Smallridge, R.C. (1996) Postpartum thyroid dysunction: A frequently undiagnosed endocrine disorder. Endocrinologist. 6, 44–50.

    Google Scholar 

  31. Nilsson, M., Husmark, J., Bjokman, U., Ericson, L.E. (1998) Cytokines and thyroid epithelial integrity: Interleukin-1 a induces dissociation of the junctional complex and paracellular leakage in filter-cultured human hydrolytes. J. Clin. Endocrinol. Metab. 83, 945–952.

    Article  PubMed  CAS  Google Scholar 

  32. Weetman, A.P., Ajjan, R.A., Watson, P.F. (1997) Cytokines and Graves’ disease. Baillieres Clin Endocrinol Metab 11:481–497.

    Article  PubMed  CAS  Google Scholar 

  33. Weetman, A.P., Freeman, M.A., Borysiewicz, L.K. (1990) Functional analysis of intercellular adhesion molecule-1 expressing human thyroid cells. Eur. J. Immunol. 20, 271–275.

    Article  PubMed  CAS  Google Scholar 

  34. Wu, Z., Podack, E.R., McKenzie, J.M. (1994) Perforin expression by thyroid infiltrating T cells in autoimmune thyroid disease. Clin. Exp. Immunol. 98, 470–477.

    PubMed  CAS  Google Scholar 

  35. Giordano, C., Stassi, G., De, Maria, R., (1997): Potential involvement of Fas and its Ligand on the pathogenesis of Hashimoto’s thyroiditis. Science. 275, 960–963.

    PubMed  CAS  Google Scholar 

  36. Chiovato, L., Bassi, P., Santini, F. (1993) Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J. Clin. Endocrinol. Metab. 77, 1700–1705.

    Article  PubMed  CAS  Google Scholar 

  37. Simons, P.J., Delemarre, F.G.A., Drexhage, H.A. (1998) Antignen-presenting dendritic cells as regulators of the growth of hydrolytes: A role of interleukin-1b and interleukin-6. Endocrinology. 139, 148–3156.

    Article  Google Scholar 

  38. Hegedus, L., Hansen, J.M., Feldt-Rasmussen, U., Hansen, B.M., and Moier-Madsen, M. (1991). Influence of thyroxine treatment on thyroid size and anti-thyroid peroxidase antibodies in Hashimoto’s thyroiditis. Clin. Endocrinol. 35, 235–238.

    Article  CAS  Google Scholar 

  39. Volpe R. (1994) Evidence that the immunosuppressive effects of antithyroid drugs are mediated through actions on the thyroid cell, modulating thyrocyte-immunocyte signaling. Thyroid. 4, 217–221.

    PubMed  CAS  Google Scholar 

  40. Lee S, Scherberg N, DeGroot LJ, et al. (1998) Induction of oral tolerance in human autoimmune thyroid disease. Thyroid. 8, 229–234.

    PubMed  CAS  Google Scholar 

  41. Baker, J.R. Jr., Fosso, C.K. (1993) Immunological aspects of cancers arising from thyroid follicular cells. Endocr. Rev. 13, 729–746.

    Article  Google Scholar 

  42. Matsuzuka, F.M., Miyauchi, A., Katyama, S. (1993), Clinical aspects of primary thyroid lymphoma: Diagnosis and treatment based on our experience of 119 cases. Thyroid. 3, 93–99.

    Article  PubMed  CAS  Google Scholar 

  43. Giani, C., Fierabracci, P., Bonacci, R. (1996) Relationship between breast cancer and thyroid disease: Relevance of autoimmune thyroid disorders in breast malignancy. J. Clin. Endocrinol. Metab. 81, 990–994.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Swain, M., Swain, T. & Mohanty, B.K. Autoimmune thyroid disorders—An update. Indian J Clin Biochem 20, 9–17 (2005). https://doi.org/10.1007/BF02893034

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02893034

Key Words

Navigation